From the webinar, i get the impression that they are not going to get any revenue until Q2 2025... FDA for heart failure is also around Q2 / Q3 2025. Can anyone comment on that? Just want to cross validate my understanding from the webinar.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $132.3M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.0¢ | $134.4K | 661.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 37400 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 7271 | 1 |
View Market Depth
| Last trade - 16.10pm 08/08/2025 (20 minute delay) ? |
| EIQ (ASX) Chart |